Back
Nektar Therapeutics Vs. Rigel Pharmaceuticals Industry Stock Comparison
Sell
46
NKTR
Nektar Therapeutics
Last Price:
1.80
Seasonality Move:
-3.09%
Sell
40
RIGL
Rigel Pharmaceuticals
Last Price:
0.98
Seasonality Move:
0.16%
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.83. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Rigel Pharmaceuticals (RIGL)
is a Sell
Is Rigel Pharmaceuticals a Buy, Sell or Hold?
- The current Rigel Pharmaceuticals [RIGL] share price is $0.97. The Score for RIGL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- RIGL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals's stock price today?
-
The Rigel Pharmaceuticals share price today is $0.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIGL is experiencing slight selling pressure.
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 66.94 | Buy |
| Chaikin Money Flow: | 638017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.69) | Buy |
| Bollinger Bands (100): | (0.54 - 1.34) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 35.3 | Sell |
| Chaikin Money Flow: | -173260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.18) | Sell |
| Bollinger Bands (100): | (1.12 - 1.44) | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Buy |
| 20-day SMA: | 1.54 | Buy |
| 50-day SMA: | 1.26 | Buy |
| 200-day SMA: | 0.76 | Buy |
| 8-day EMA: | 1.71 | Buy |
| 20-day EMA: | 1.57 | Buy |
| 50-day EMA: | 1.31 | Buy |
| 200-day EMA: | 1.05 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.04 | Sell |
| 20-day SMA: | 1.08 | Sell |
| 50-day SMA: | 1.25 | Sell |
| 200-day SMA: | 1.17 | Sell |
| 8-day EMA: | 1.02 | Sell |
| 20-day EMA: | 1.08 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.23 | Sell |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.21 per share.
Rigel Pharmaceuticals Earnings Growth & RIGL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.11 per share, and an increase next year of $0.13 per share.
Nektar Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||